Ladenburg Thalmann Financial Services’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-11,839
Closed -$962K 4814
2014
Q4
$962K Buy
11,839
+9,997
+543% +$777K 0.02% 617
2014
Q3
$122K Sell
1,842
-45
-2% -$2.96K ﹤0.01% 1492
2014
Q2
$132K Buy
1,887
+753
+66% +$51.2K ﹤0.01% 1432
2014
Q1
$83K Buy
1,134
+834
+278% +$62.2K ﹤0.01% 1622
2013
Q4
$21K Hold
300
﹤0.01% 2528
2013
Q3
$19K Hold
300
﹤0.01% 2504
2013
Q2
$14K Buy
+300
New +$14.7K ﹤0.01% 2558

Ladenburg Thalmann Financial Services's CBST Position: Q1 2015 in Review

Ladenburg Thalmann Financial Services sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 11,839 shares — an estimated $962K sold.

Ladenburg Thalmann Financial Services first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $962K in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Ladenburg Thalmann Financial Services reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 11,839 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $962K.
  • Ladenburg Thalmann Financial Services first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Ladenburg Thalmann Financial Services's CUBIST PHARMACEUTICALS INC position peaked at $962K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2015, filed 15 May 2015.